{"id":"W2782542268","doi":"10.1182/blood.v130.suppl_1.739.739","title":"Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM): Updated Efficacy and Safety Analysis of Pollux","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Dexamethasone; Internal medicine; Interim analysis; Pomalidomide; Oncology; Multiple myeloma; Bortezomib; Clinical endpoint; Neutropenia; Ixazomib; Progression-free survival; Carfilzomib; Gastroenterology; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002928167,0.0005955333,0.001961309,0.0005932819,0.0002248376,0.001192381,0.0008299229,0.0005364438,0.002881796],"category_scores_gemma":[0.002242784,0.0004132367,0.001971337,0.0005176846,0.0005210628,0.0007585992,0.0004953378,0.001630816,0.0003621496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001007923,"about_ca_system_score_gemma":0.0006789555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004729509,"about_ca_topic_score_gemma":0.001626874,"domain_scores_codex":[0.9985967,0.0008526348,0.0001110973,0.0001700083,0.0001736712,0.00009582989],"domain_scores_gemma":[0.9985555,0.0004522121,0.0005718878,0.00009144768,0.00007764388,0.0002514324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7509178,0.005494095,0.01115627,0.001937764,0.006670079,0.0001159362,0.0001896197,0.002265503,0.007786769,0.0004472503,0.003543797,0.2094752],"study_design_scores_gemma":[0.5701036,0.33825,0.05197442,0.0005546172,0.01287849,0.000825488,0.0001941571,0.003648307,0.006695335,0.001106129,0.01365272,0.0001167683],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722801,0.02065311,0.0006939277,0.000908751,0.0002188506,0.0009320344,0.001345723,0.0001057827,0.002861719],"genre_scores_gemma":[0.9898646,0.004721961,0.001099935,0.001001893,0.0002062118,0.0006002687,0.001368314,0.00001618771,0.001120588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002928167,"threshold_uncertainty_score":0.01548582,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04574990434246723,"score_gpt":0.3348571041925786,"score_spread":0.2891071998501114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}